Scott M. Filippone

Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism

Juan Valle Raleigh, Adolfo G Mauro, Teja Devarakonda et al. · Cardiovascular Research · 2016 · 97 citations · Full text

Medicine, Cardiology, Pharmacology +15

Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling

Anindita Das, Fadi N. Salloum, Scott M. Filippone et al. · Basic Research in Cardiology · 2015 · 73 citations · Full text

Medicine, Cardiology, Pharmacology +17

Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK

Scott M. Filippone, Arun Samidurai, Sean K. Roh et al. · Oxidative Medicine and Cellular Longevity · 2017 · 51 citations · Full text

Medicine, Cardiology, Pharmacology +15

Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells

Sayantanee Das, Scott M. Filippone, Denise S. Williams et al. · Molecular and Cellular Biochemistry · 2016 · 30 citations

Medicine, Oncology, Pharmacology +14

Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes

Arun Samidurai, Ramzi Ockaili, Chad Cain et al. · iScience · 2020 · 17 citations · Full text

Life Sciences, Cardiology, Pharmacology +16